• Clinical Insights: September 29, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval No new update. New Formulation Approval No new update. New Indication/Dosage Approval NucalaTM (mepolizumab) Injection – New Approved Indication – September 25, 2020 – GlaxoSmithKline plc (GSK) announced… Read more »

  • Clinical Insights: September 22, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval No new update. New Formulation Approval No new update. New Indication/Dosage Approval No new update. New Drug Shortage September 21, 2020  Indinavir (CRIXIVAN) Capsules (Discontinuation) September 18, 2020 Finasteride… Read more »

  • Clinical Insights: September 15, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval GavretoTM (pralsetinib) Capsules – New Drug Approval – September 4, 2020 – Roche announced that the United States (US) Food and Drug Administration (FDA) has approved Gavreto™ (pralsetinib)… Read more »

  • Clinical Insights: September 8, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval Onureg® (azacitidine) Tablets – New Drug Approval – September 1, 2020 – The Food and Drug Administration approved azacitidine tablets (Onureg®, Celgene Corporation) for continued treatment of patients… Read more »

  • Clinical Insights: September 1, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval  Winlevi® (clascoterone) Cream – New Drug Approval – August 27, 2020 – Cassiopea SpA announced that the United States Food and Drug Administration (FDA) approved Winlevi® (clascoterone cream… Read more »

  • Clinical Insights: August 25, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval Kesimpta® (ofatumumab) Injection – New Drug Approval – August 20, 2020 – Novartis announced that the US Food and Drug Administration (FDA) has approved Kesimpta® (ofatumumab, formerly OMB157)… Read more »

  • Clinical Insights: August 18, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval EnspryngTM (satralizumab-mwge) Injection – New Drug Approval – August 17, 2020 – The U.S. Food and Drug Administration has approved EnspryngTM (satralizumab-mwge) for the treatment of neuromyelitis optica… Read more »

  • Clinical Insights: August 11, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval  OlinvykTM (oliceridine) Injection – New Drug Approval – August 7, 2020 – The U.S. Food and Drug Administration approved OlinvykTM (oliceridine), an opioid agonist for the management of… Read more »

  • Clinical Insights: August 4, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval Monjuvi® (tafasitamab-cxix) Injection – New Drug Approval – July 31, 2020 – MorphoSys AG announced that the U.S. Food and Drug Administration (FDA) has approved Monjuvi® (tafasitamab-cxix) in… Read more »

  • Clinical Insights: July 28, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval TecartusTM (brexucabtagene autoleucel) – New Drug Approval – July 24, 2020 – Kite, a Gilead Company announced that the U.S. Food and Drug Administration (FDA) has granted accelerated… Read more »